Matches in Wikidata for { <http://www.wikidata.org/entity/Q80179935> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q80179935 description "artículu científicu espublizáu en xunetu de 2006" @default.
- Q80179935 description "im Juli 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80179935 description "scientific article published on 25 July 2006" @default.
- Q80179935 description "wetenschappelijk artikel" @default.
- Q80179935 description "наукова стаття, опублікована в липні 2006" @default.
- Q80179935 name "Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteins" @default.
- Q80179935 name "Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteins" @default.
- Q80179935 type Item @default.
- Q80179935 label "Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteins" @default.
- Q80179935 label "Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteins" @default.
- Q80179935 prefLabel "Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteins" @default.
- Q80179935 prefLabel "Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteins" @default.
- Q80179935 P1433 Q80179935-CB1606F9-ECCC-46A7-BDEC-5AB60E00E241 @default.
- Q80179935 P1476 Q80179935-8EF5854A-E0DF-46EC-9C66-335A8B9A7C9C @default.
- Q80179935 P2093 Q80179935-6EC051F9-C84E-43A8-A133-0C00414B1C96 @default.
- Q80179935 P2093 Q80179935-70A454C7-E9AF-41B0-B27B-5DA1F5AB5D6D @default.
- Q80179935 P2093 Q80179935-E66DD898-C975-495D-AEE1-1AC170E94909 @default.
- Q80179935 P304 Q80179935-767C64A9-C1B7-43B7-A617-875AA5692632 @default.
- Q80179935 P31 Q80179935-2F8A6947-A4D9-4222-BCCB-01B5BCF3AD22 @default.
- Q80179935 P356 Q80179935-41618BEB-043E-49BD-A285-3A469A944F79 @default.
- Q80179935 P433 Q80179935-09E1229D-36A7-4D48-BD9A-2CB7CD4C5212 @default.
- Q80179935 P478 Q80179935-763280B2-53A5-4368-B420-489DE34028C5 @default.
- Q80179935 P50 Q80179935-082CD418-BE57-4169-9B3C-9B1484B912D6 @default.
- Q80179935 P50 Q80179935-268FCE80-D3DB-4925-84C7-C7C4A44C4495 @default.
- Q80179935 P50 Q80179935-8336AEAF-C74C-409B-B8FE-79F91C60620E @default.
- Q80179935 P50 Q80179935-9DC429AD-DC4F-44F5-B845-A17DCC254D46 @default.
- Q80179935 P50 Q80179935-C3F2D22F-2BF3-4EB7-B0CC-030FA92376D1 @default.
- Q80179935 P577 Q80179935-018ABB53-A0F3-4098-BD8E-A91C9215FE3A @default.
- Q80179935 P698 Q80179935-09B9F4D8-ED2D-4A30-90D7-D92CA52D5EFC @default.
- Q80179935 P921 Q80179935-7BFB3510-2F2F-4AAA-851B-4752E512F7A1 @default.
- Q80179935 P356 J.JINORGBIO.2006.07.003 @default.
- Q80179935 P698 16938349 @default.
- Q80179935 P1433 Q3186919 @default.
- Q80179935 P1476 "Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteins" @default.
- Q80179935 P2093 "Alexander V Rudnev" @default.
- Q80179935 P2093 "Lidia S Foteeva" @default.
- Q80179935 P2093 "Roland Berger" @default.
- Q80179935 P304 "1819-1826" @default.
- Q80179935 P31 Q13442814 @default.
- Q80179935 P356 "10.1016/J.JINORGBIO.2006.07.003" @default.
- Q80179935 P433 "11" @default.
- Q80179935 P478 "100" @default.
- Q80179935 P50 Q38800373 @default.
- Q80179935 P50 Q38800395 @default.
- Q80179935 P50 Q42173444 @default.
- Q80179935 P50 Q87890843 @default.
- Q80179935 P50 Q88284603 @default.
- Q80179935 P577 "2006-07-25T00:00:00Z" @default.
- Q80179935 P698 "16938349" @default.
- Q80179935 P921 Q861 @default.